Skip to main content
Erschienen in: Rheumatology International 2/2019

17.09.2018 | Review

Diagnosis and differential diagnosis of large-vessel vasculitides

verfasst von: Gokhan Keser, Kenan Aksu

Erschienen in: Rheumatology International | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

There are no universally accepted diagnostic criteria for large-vessel vasculitides (LVV), including giant cell arteritis (GCA) and Takayasu arteritis (TAK). Currently, available classification criteria cannot be used for the diagnosis of GCA and TAK. Early diagnosis of these two diseases is quite challenging in clinical practice and may be accomplished only by combining the patient symptoms, physical examination findings, blood test results, imaging findings, and biopsy results, if available. Awareness of red flags which lead the clinician to investigate TAK in a young patient with persistent systemic inflammation is helpful for the early diagnosis. It should be noted that clinical presentation may be highly variable in a subgroup of GCA patients with predominant large-vessel involvement (LVI) and without prominent cranial symptoms. Imaging modalities are especially helpful for the diagnosis of this subgroup. Differential diagnosis between older patients with TAK and this subgroup of GCA patients presenting with LVI may be difficult. Various pathologies may mimic LVV either by causing systemic inflammation and constitutional symptoms, or by causing lumen narrowing with or without aneurysm formation in the aorta and its branches. Differential diagnosis of aortitis is crucial. Infectious aortitis including mycotic aneurysms due to septicemia or endocarditis, as well as causes such as syphilis and mycobacterial infections should always be excluded. On the other hand, the presence of non-infectious aortitis is not unique for TAK and GCA. It should be noted that aortitis, other large-vessel involvement or both, may occasionally be seen in various other autoimmune pathologies including ANCA-positive vasculitides, Behçet’s disease, ankylosing spondylitis, sarcoidosis, and Sjögren’s syndrome. Besides, aortitis may be idiopathic and isolated. Atherosclerosis should always be considered in the differential diagnosis of LVV. Other pathologies which may mimic LVV include, but not limited to, congenital causes of aortic coarctation and middle aortic syndrome, immunoglobulin G4-related disease, and hereditary disorders of connective tissue such as Marfan syndrome and Ehler–Danlos syndrome.
Literatur
1.
Zurück zum Zitat Jennette JC, Falk R, Bacon P, Basu N, Cid M, Ferrario F, Flores-Suarez L, Gross W, Guillevin L, Hagen E (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11CrossRef Jennette JC, Falk R, Bacon P, Basu N, Cid M, Ferrario F, Flores-Suarez L, Gross W, Guillevin L, Hagen E (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11CrossRef
2.
Zurück zum Zitat Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, Brunner HI, Ogawa R, Felson D, Ogdie A (2015) Distinctions between diagnostic and classification criteria? Arthritis Care Res 67(7):891–897CrossRef Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, Brunner HI, Ogawa R, Felson D, Ogdie A (2015) Distinctions between diagnostic and classification criteria? Arthritis Care Res 67(7):891–897CrossRef
3.
Zurück zum Zitat de Souza AWS, de Carvalho JF (2014) Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun 48:79–83CrossRefPubMed de Souza AWS, de Carvalho JF (2014) Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun 48:79–83CrossRefPubMed
4.
Zurück zum Zitat Ishikawa K (1988) Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu’s arteriopathy. J Am Coll Cardiol 12(4):964–972CrossRefPubMed Ishikawa K (1988) Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu’s arteriopathy. J Am Coll Cardiol 12(4):964–972CrossRefPubMed
5.
Zurück zum Zitat Sharma B, Jain S, Suri S, Numano F (1996) Diagnostic criteria for Takayasu arteritis. Int J Cardiol 54:S127–S133CrossRef Sharma B, Jain S, Suri S, Numano F (1996) Diagnostic criteria for Takayasu arteritis. Int J Cardiol 54:S127–S133CrossRef
6.
Zurück zum Zitat Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie J, Lightfoot RW (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMed Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie J, Lightfoot RW (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMed
7.
Zurück zum Zitat Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie J (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum Off J Am Coll Rheumatol 33(8):1122–1128CrossRef Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie J (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum Off J Am Coll Rheumatol 33(8):1122–1128CrossRef
8.
Zurück zum Zitat Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E, Cimmino MA, Clark E, Dasgupta B (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77(5):636–643CrossRefPubMed Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E, Cimmino MA, Clark E, Dasgupta B (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77(5):636–643CrossRefPubMed
9.
Zurück zum Zitat Sait MR, Lepore M, Kwasnicki R, Allington J, Balasubramanian R, Somasundaram SK, Vashisht R, Barkeji M (2017) The 2016 revised ACR criteria for diagnosis of giant cell arteritis—our case series: can this avoid unnecessary temporal artery biopsies? Int J Surg 9:19–23 Sait MR, Lepore M, Kwasnicki R, Allington J, Balasubramanian R, Somasundaram SK, Vashisht R, Barkeji M (2017) The 2016 revised ACR criteria for diagnosis of giant cell arteritis—our case series: can this avoid unnecessary temporal artery biopsies? Int J Surg 9:19–23
10.
Zurück zum Zitat Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, Watts R, Merkel PA, Luqmani RA (2013) ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol 17(5):619–621CrossRefPubMed Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, Watts R, Merkel PA, Luqmani RA (2013) ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol 17(5):619–621CrossRefPubMed
11.
Zurück zum Zitat Kobayashi S, Fujimoto S (2013) Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol 17(5):611–614CrossRefPubMedPubMedCentral Kobayashi S, Fujimoto S (2013) Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol 17(5):611–614CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929CrossRefPubMed Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929CrossRefPubMed
13.
Zurück zum Zitat Salvarani C, Cantini F, Boiardi L, Hunder G (2003) Laboratory investigations useful in giant cell arteritis and Takayasu’s arteritis. Clin Exp Rheumatol 21(6:SUPP/32):S23–S28PubMed Salvarani C, Cantini F, Boiardi L, Hunder G (2003) Laboratory investigations useful in giant cell arteritis and Takayasu’s arteritis. Clin Exp Rheumatol 21(6:SUPP/32):S23–S28PubMed
15.
Zurück zum Zitat Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care Res 45(2):140–145CrossRef Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care Res 45(2):140–145CrossRef
16.
Zurück zum Zitat Eklund KK, Niemi K, Kovanen P (2012) Immune functions of serum amyloid A. Crit Rev Immunol 32(4):335–348CrossRefPubMed Eklund KK, Niemi K, Kovanen P (2012) Immune functions of serum amyloid A. Crit Rev Immunol 32(4):335–348CrossRefPubMed
17.
Zurück zum Zitat Keser G, Aksu K, Direskeneli H (2017) Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited. Rheumatology 57(5):784–790CrossRef Keser G, Aksu K, Direskeneli H (2017) Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited. Rheumatology 57(5):784–790CrossRef
18.
Zurück zum Zitat Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, Mantovani A (2014) The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol 165(3):165–178CrossRefPubMed Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, Mantovani A (2014) The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol 165(3):165–178CrossRefPubMed
19.
Zurück zum Zitat Alibaz-Oner F, Aksu K, Yentur S, Keser G, Saruhan-Direskeneli G, Direskeneli H (2016) Plasma pentraxin-3 levels in patients with Takayasu’s arteritis during routine follow-up. Clin Exp Rheumatol 34(3 Suppl 97):S73–S76PubMed Alibaz-Oner F, Aksu K, Yentur S, Keser G, Saruhan-Direskeneli G, Direskeneli H (2016) Plasma pentraxin-3 levels in patients with Takayasu’s arteritis during routine follow-up. Clin Exp Rheumatol 34(3 Suppl 97):S73–S76PubMed
20.
Zurück zum Zitat Tombetti E, Di Chio MC, Sartorelli S, Papa M, Salerno A, Bottazzi B, Bozzolo EP, Greco M, Rovere-Querini P, Baldissera E (2014) Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther 16(6):479CrossRefPubMedPubMedCentral Tombetti E, Di Chio MC, Sartorelli S, Papa M, Salerno A, Bottazzi B, Bozzolo EP, Greco M, Rovere-Querini P, Baldissera E (2014) Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther 16(6):479CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Dagna L, Salvo F, Tiraboschi M, Bozzolo EP, Franchini S, Doglioni C, Manfredi AA, Baldissera E, Sabbadini MG (2011) Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann Intern Med 155(7):425–433CrossRefPubMed Dagna L, Salvo F, Tiraboschi M, Bozzolo EP, Franchini S, Doglioni C, Manfredi AA, Baldissera E, Sabbadini MG (2011) Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann Intern Med 155(7):425–433CrossRefPubMed
22.
Zurück zum Zitat Barra L, Kanji T, Malette J, Pagnoux C, Vasc C (2018) Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis. Autoimmun Rev 17(2):175–187CrossRefPubMed Barra L, Kanji T, Malette J, Pagnoux C, Vasc C (2018) Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis. Autoimmun Rev 17(2):175–187CrossRefPubMed
23.
Zurück zum Zitat Mavrogeni S, Dimitroulas T, Chatziioannou SN, Kitas G (2013) The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum 42(4):401–412CrossRefPubMed Mavrogeni S, Dimitroulas T, Chatziioannou SN, Kitas G (2013) The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum 42(4):401–412CrossRefPubMed
24.
Zurück zum Zitat Muratore F, Pipitone N, Salvarani C, Schmidt WA (2016) Imaging of vasculitis: state of the art. Best Pract Res Clin Rheumatol 30(4):688–706CrossRefPubMed Muratore F, Pipitone N, Salvarani C, Schmidt WA (2016) Imaging of vasculitis: state of the art. Best Pract Res Clin Rheumatol 30(4):688–706CrossRefPubMed
25.
26.
Zurück zum Zitat Hartlage GR, Palios J, Barron BJ, Stillman AE, Bossone E, Clements SD, Lerakis S (2014) Multimodality imaging of aortitis. JACC Cardiovasc Imaging 7(6):605–619CrossRefPubMed Hartlage GR, Palios J, Barron BJ, Stillman AE, Bossone E, Clements SD, Lerakis S (2014) Multimodality imaging of aortitis. JACC Cardiovasc Imaging 7(6):605–619CrossRefPubMed
27.
Zurück zum Zitat Papa M, De Cobelli F, Baldissera E, Dagna L, Schiani E, Sabbadini M, Del Maschio A (2012) Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. Am J Roentgenol 198(3):W279–W284CrossRef Papa M, De Cobelli F, Baldissera E, Dagna L, Schiani E, Sabbadini M, Del Maschio A (2012) Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. Am J Roentgenol 198(3):W279–W284CrossRef
28.
Zurück zum Zitat Eshet Y, Pauzner R, Goitein O, Langevitz P, Eshed I, Hoffmann C, Konen E (2011) The limited role of MRI in long-term follow-up of patients with Takayasu’s arteritis. Autoimmun Rev 11(2):132–136CrossRefPubMed Eshet Y, Pauzner R, Goitein O, Langevitz P, Eshed I, Hoffmann C, Konen E (2011) The limited role of MRI in long-term follow-up of patients with Takayasu’s arteritis. Autoimmun Rev 11(2):132–136CrossRefPubMed
29.
Zurück zum Zitat Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS (2002) Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum Off J Am Coll Rheumatol 46(6):1634–1642CrossRef Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS (2002) Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum Off J Am Coll Rheumatol 46(6):1634–1642CrossRef
30.
Zurück zum Zitat Garg SK, Mohan S, Kumar S (2011) Diagnostic value of 3D contrast-enhanced magnetic resonance angiography in Takayasu’s arteritis—a comparative study with digital subtraction angiography. Eur Radiol 21(8):1658–1666CrossRefPubMed Garg SK, Mohan S, Kumar S (2011) Diagnostic value of 3D contrast-enhanced magnetic resonance angiography in Takayasu’s arteritis—a comparative study with digital subtraction angiography. Eur Radiol 21(8):1658–1666CrossRefPubMed
31.
Zurück zum Zitat Chung JW, Kim H-C, Choi YH, Kim SJ, Lee W, Park JH (2007) Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 45(5):906–914CrossRefPubMed Chung JW, Kim H-C, Choi YH, Kim SJ, Lee W, Park JH (2007) Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 45(5):906–914CrossRefPubMed
32.
Zurück zum Zitat Yoshida S, Akiba H, Tamakawa M, Yama N, Takeda M, Hareyama M, Nakata T, Shimamoto K (2001) The spectrum of findings in supra-aortic Takayasu’s arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Intervent Radiol 24(2):117–121CrossRefPubMed Yoshida S, Akiba H, Tamakawa M, Yama N, Takeda M, Hareyama M, Nakata T, Shimamoto K (2001) The spectrum of findings in supra-aortic Takayasu’s arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Intervent Radiol 24(2):117–121CrossRefPubMed
33.
Zurück zum Zitat Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W (2016) The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20(90):1–238CrossRefPubMedPubMedCentral Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W (2016) The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20(90):1–238CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA (2017) Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology 56(9):1479–1483CrossRefPubMed Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA (2017) Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology 56(9):1479–1483CrossRefPubMed
35.
Zurück zum Zitat Germanò G, Muratore F, Cimino L, Lo Gullo A, Possemato N, Macchioni P, Cavazza A, Pipitone N, Boiardi L, Salvarani C (2014) Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology 54(3):400–404CrossRefPubMed Germanò G, Muratore F, Cimino L, Lo Gullo A, Possemato N, Macchioni P, Cavazza A, Pipitone N, Boiardi L, Salvarani C (2014) Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology 54(3):400–404CrossRefPubMed
36.
Zurück zum Zitat Karapolat I, Kalfa M, Keser G, Yalçin M, Inal V, Kumanlioğlu K, Pirildar T, Aksu K (2013) Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu’s arteritis. Clin Exp Rheumatol 31(1 Suppl 75):S15–S21PubMed Karapolat I, Kalfa M, Keser G, Yalçin M, Inal V, Kumanlioğlu K, Pirildar T, Aksu K (2013) Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu’s arteritis. Clin Exp Rheumatol 31(1 Suppl 75):S15–S21PubMed
37.
Zurück zum Zitat Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S (2014) F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol 21(5):993–1000CrossRefPubMed Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S (2014) F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol 21(5):993–1000CrossRefPubMed
38.
Zurück zum Zitat Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J-I, Hirao K, Isobe M (2012) Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 5(4):422–429CrossRefPubMed Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J-I, Hirao K, Isobe M (2012) Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 5(4):422–429CrossRefPubMed
39.
Zurück zum Zitat Cheng Y, Lv N, Wang Z, Chen B, Dang A (2013) 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol 31(1 Suppl 75):S22–S27PubMed Cheng Y, Lv N, Wang Z, Chen B, Dang A (2013) 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol 31(1 Suppl 75):S22–S27PubMed
40.
Zurück zum Zitat Incerti E, Tombetti E, Fallanca F, Baldissera EM, Alongi P, Tombolini E, Sartorelli S, Sabbadini MG, Papa M, De Cobelli F (2017) 18 F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging 44(7):1109–1118CrossRefPubMed Incerti E, Tombetti E, Fallanca F, Baldissera EM, Alongi P, Tombolini E, Sartorelli S, Sabbadini MG, Papa M, De Cobelli F (2017) 18 F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging 44(7):1109–1118CrossRefPubMed
41.
Zurück zum Zitat Einspieler I, Thürmel K, Pyka T, Eiber M, Wolfram S, Moog P, Reeps C, Essler M (2015) Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging 42(7):1012–1024CrossRefPubMed Einspieler I, Thürmel K, Pyka T, Eiber M, Wolfram S, Moog P, Reeps C, Essler M (2015) Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging 42(7):1012–1024CrossRefPubMed
42.
Zurück zum Zitat Vanoli M, Daina E, Salvarani C, Sabbadini M, Rossi C, Bacchiani G, Schieppati A, Baldissera E, Bertolini G (2005) Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Care Res 53(1):100–107CrossRef Vanoli M, Daina E, Salvarani C, Sabbadini M, Rossi C, Bacchiani G, Schieppati A, Baldissera E, Bertolini G (2005) Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Care Res 53(1):100–107CrossRef
43.
Zurück zum Zitat Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer H, Seyahi E, Akar S, Onen F (2009) Takayasu’s arteritis in Turkey—clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(1):S59PubMed Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer H, Seyahi E, Akar S, Onen F (2009) Takayasu’s arteritis in Turkey—clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(1):S59PubMed
44.
Zurück zum Zitat Park MC, Lee SW, Park YB, Chung N, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34(4):284–292CrossRefPubMed Park MC, Lee SW, Park YB, Chung N, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34(4):284–292CrossRefPubMed
45.
Zurück zum Zitat Grayson PC, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Monach PA, Seo P (2013) New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol 40(11):1905–1912CrossRefPubMedPubMedCentral Grayson PC, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Monach PA, Seo P (2013) New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol 40(11):1905–1912CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y (2010) EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69(5):798–806CrossRefPubMed Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y (2010) EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69(5):798–806CrossRefPubMed
47.
Zurück zum Zitat Sheikhzadeh A, Ghabussi P, Razi M (1982) Occlusive thromboaortopathy (Takayasu’s disease): clinical findings and angiographic classification. Herz 7(5):325–330PubMed Sheikhzadeh A, Ghabussi P, Razi M (1982) Occlusive thromboaortopathy (Takayasu’s disease): clinical findings and angiographic classification. Herz 7(5):325–330PubMed
48.
Zurück zum Zitat Nasu T (1982) Takayasu’s truncoarteritis. Pulseless disease or aortitis syndrome. Acta Pathol Jpn 32:117–131PubMed Nasu T (1982) Takayasu’s truncoarteritis. Pulseless disease or aortitis syndrome. Acta Pathol Jpn 32:117–131PubMed
49.
Zurück zum Zitat Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54:S155–S163CrossRefPubMed Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54:S155–S163CrossRefPubMed
50.
Zurück zum Zitat Nazareth R, Mason J (2010) Takayasu arteritis: severe consequences of delayed diagnosis. QJM 104(9):797–800 Nazareth R, Mason J (2010) Takayasu arteritis: severe consequences of delayed diagnosis. QJM 104(9):797–800
51.
Zurück zum Zitat Chugh KS, Sakhuja V (1992) Takayasu’s arteritis as a cause of renovascular hypertension in Asian countries. Am J Nephrol 12(1–2):1–8CrossRefPubMed Chugh KS, Sakhuja V (1992) Takayasu’s arteritis as a cause of renovascular hypertension in Asian countries. Am J Nephrol 12(1–2):1–8CrossRefPubMed
54.
Zurück zum Zitat Brack A, Martinez-Taboada V, Stanson A, Goronzy J, Weyand C (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum Off J Am Coll Rheumatol 42(2):311–317CrossRef Brack A, Martinez-Taboada V, Stanson A, Goronzy J, Weyand C (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum Off J Am Coll Rheumatol 42(2):311–317CrossRef
55.
Zurück zum Zitat de Boysson H, Daumas A, Vautier M, Parienti J-J, Liozon E, Lambert M, Samson M, Ebba M, Dumont A, Sultan A (2018) Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev 17(4):391–398CrossRefPubMed de Boysson H, Daumas A, Vautier M, Parienti J-J, Liozon E, Lambert M, Samson M, Ebba M, Dumont A, Sultan A (2018) Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev 17(4):391–398CrossRefPubMed
57.
Zurück zum Zitat Taylor-Gjevre R, Vo M, Shukla D, Resch L (2005) Temporal artery biopsy for giant cell arteritis. J Rheumatol 32(7):1279–1282PubMed Taylor-Gjevre R, Vo M, Shukla D, Resch L (2005) Temporal artery biopsy for giant cell arteritis. J Rheumatol 32(7):1279–1282PubMed
58.
Zurück zum Zitat Breuer GS, Nesher G, Nesher R (2009) Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol 36(4):794–796CrossRefPubMed Breuer GS, Nesher G, Nesher R (2009) Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol 36(4):794–796CrossRefPubMed
59.
Zurück zum Zitat Niederkohr RD, Levin LA (2007) A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Investig Ophthalmol Vis Sci 48(2):675–680CrossRef Niederkohr RD, Levin LA (2007) A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Investig Ophthalmol Vis Sci 48(2):675–680CrossRef
60.
Zurück zum Zitat Maksimowicz-McKinnon K, Clark TM, Hoffman GS (2009) Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore) 88(4):221–226CrossRef Maksimowicz-McKinnon K, Clark TM, Hoffman GS (2009) Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore) 88(4):221–226CrossRef
61.
Zurück zum Zitat O’Neill L, Ponte C, Sznajd J, Rodrigues AP, Seeliger B, Luqmani RA (2015) Giant cell arteritis and Takayasu arteritis: are they a different spectrum of the same disease? IJR 10(Suppl 1):S11–S21 O’Neill L, Ponte C, Sznajd J, Rodrigues AP, Seeliger B, Luqmani RA (2015) Giant cell arteritis and Takayasu arteritis: are they a different spectrum of the same disease? IJR 10(Suppl 1):S11–S21
62.
Zurück zum Zitat Furuta S, Cousins C, Chaudhry A, Jayne D (2015) Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J Rheumatol 42(2):300–308CrossRefPubMed Furuta S, Cousins C, Chaudhry A, Jayne D (2015) Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J Rheumatol 42(2):300–308CrossRefPubMed
64.
Zurück zum Zitat Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J (2017) Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377(4):317–328CrossRefPubMed Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J (2017) Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377(4):317–328CrossRefPubMed
65.
Zurück zum Zitat Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N (2018) Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77(3):348–354CrossRefPubMed Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N (2018) Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77(3):348–354CrossRefPubMed
66.
Zurück zum Zitat Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA (2017) Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy. Sci Rep 7:43953CrossRefPubMedPubMedCentral Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA (2017) Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy. Sci Rep 7:43953CrossRefPubMedPubMedCentral
67.
Zurück zum Zitat Carmona FD, Martín J, González-Gay MA (2015) Genetics of vasculitis. Curr Opin Rheumatol 27(1):10–17CrossRefPubMed Carmona FD, Martín J, González-Gay MA (2015) Genetics of vasculitis. Curr Opin Rheumatol 27(1):10–17CrossRefPubMed
68.
Zurück zum Zitat Stone JR, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L, Buja LM, Butany J, d’Amati G, Fallon JT (2015) Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 24(5):267–278CrossRefPubMed Stone JR, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L, Buja LM, Butany J, d’Amati G, Fallon JT (2015) Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 24(5):267–278CrossRefPubMed
69.
Zurück zum Zitat Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ (2015) Extra-cranial giant cell arteritis and Takayasu arteritis: how similar are they? Semin Arthritis Rheum 44(6):724–728CrossRefPubMed Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ (2015) Extra-cranial giant cell arteritis and Takayasu arteritis: how similar are they? Semin Arthritis Rheum 44(6):724–728CrossRefPubMed
70.
Zurück zum Zitat Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P (2012) Distribution of arterial lesions in Takayasu’s arteritis and giant cell arteritis. Ann Rheum Dis 71(8):1329–1334CrossRefPubMed Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P (2012) Distribution of arterial lesions in Takayasu’s arteritis and giant cell arteritis. Ann Rheum Dis 71(8):1329–1334CrossRefPubMed
71.
Zurück zum Zitat Saadoun D, Garrido M, Comarmond C, Desbois A, Domont F, Savey L, Terrier B, Geri G, Rosenzwajg M, Klatzmann D (2015) Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol 67(5):1353–1360CrossRefPubMed Saadoun D, Garrido M, Comarmond C, Desbois A, Domont F, Savey L, Terrier B, Geri G, Rosenzwajg M, Klatzmann D (2015) Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol 67(5):1353–1360CrossRefPubMed
72.
73.
Zurück zum Zitat Weyand CM, Younge BR, Goronzy JJ (2011) IFN-γ and IL-17-the two faces of T cell pathology in giant cell arteritis. Curr Opin Rheumatol 23(1):43–49CrossRefPubMedPubMedCentral Weyand CM, Younge BR, Goronzy JJ (2011) IFN-γ and IL-17-the two faces of T cell pathology in giant cell arteritis. Curr Opin Rheumatol 23(1):43–49CrossRefPubMedPubMedCentral
74.
Zurück zum Zitat Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ (2012) Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup. Arthritis Care Res 64(7):1079–1083 Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ (2012) Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup. Arthritis Care Res 64(7):1079–1083
75.
Zurück zum Zitat Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum Off J Am Coll Rheumatol 50(7):2296–2304CrossRef Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum Off J Am Coll Rheumatol 50(7):2296–2304CrossRef
76.
Zurück zum Zitat Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146(9):621–630CrossRefPubMed Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146(9):621–630CrossRefPubMed
77.
Zurück zum Zitat Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL (2017) A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis. Arthritis Rheum 69(4):837–845CrossRef Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL (2017) A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis. Arthritis Rheum 69(4):837–845CrossRef
78.
Zurück zum Zitat Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL (2017) A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheumatol 69(4):846–853CrossRefPubMedPubMedCentral Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL (2017) A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheumatol 69(4):846–853CrossRefPubMedPubMedCentral
79.
Zurück zum Zitat Thomas K, Vassilopoulos D (2017) Infections and vasculitis. Curr Opin Rheumatol 29(1):17–23CrossRefPubMed Thomas K, Vassilopoulos D (2017) Infections and vasculitis. Curr Opin Rheumatol 29(1):17–23CrossRefPubMed
80.
Zurück zum Zitat Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, ParIès J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Care Res 57(8):1473–1480CrossRef Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, ParIès J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Care Res 57(8):1473–1480CrossRef
82.
Zurück zum Zitat Scheel A, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Müller G, Strutz F (2004) Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 63(11):1507–1510CrossRefPubMedPubMedCentral Scheel A, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Müller G, Strutz F (2004) Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 63(11):1507–1510CrossRefPubMedPubMedCentral
83.
Zurück zum Zitat Tavora F, Burke A (2006) Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu’s and giant cell aortitis. Pathology (Phila) 38(4):302–308 Tavora F, Burke A (2006) Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu’s and giant cell aortitis. Pathology (Phila) 38(4):302–308
85.
Zurück zum Zitat Foote EA, Postier RG, Greenfield RA, Bronze MS (2005) Infectious aortitis. Curr Treat Options Cardiovasc Med 7(2):89–97CrossRefPubMed Foote EA, Postier RG, Greenfield RA, Bronze MS (2005) Infectious aortitis. Curr Treat Options Cardiovasc Med 7(2):89–97CrossRefPubMed
86.
Zurück zum Zitat Khasnis A (2009) Mimics of primary systemic vasculitides. Int J Clin Rheumatol 4(5):597–609CrossRef Khasnis A (2009) Mimics of primary systemic vasculitides. Int J Clin Rheumatol 4(5):597–609CrossRef
87.
Zurück zum Zitat Malouf JF, Chandrasekaran K, Orszulak TA (2003) Mycotic aneurysms of the thoracic aorta: a diagnostic challenge. Am J Med 115(6):489–496CrossRefPubMed Malouf JF, Chandrasekaran K, Orszulak TA (2003) Mycotic aneurysms of the thoracic aorta: a diagnostic challenge. Am J Med 115(6):489–496CrossRefPubMed
89.
Zurück zum Zitat Lee W-K, Mossop PJ, Little AF, Fitt GJ, Vrazas JI, Hoang JK, Hennessy OF (2008) Infected (mycotic) aneurysms: spectrum of imaging appearances and management. Radiographics 28(7):1853–1868CrossRefPubMed Lee W-K, Mossop PJ, Little AF, Fitt GJ, Vrazas JI, Hoang JK, Hennessy OF (2008) Infected (mycotic) aneurysms: spectrum of imaging appearances and management. Radiographics 28(7):1853–1868CrossRefPubMed
90.
Zurück zum Zitat Sokalski D, Spring TC, Roberts W (2013) Large artery inflammation in systemic lupus erythematosus. Lupus 22(9):953–956CrossRefPubMed Sokalski D, Spring TC, Roberts W (2013) Large artery inflammation in systemic lupus erythematosus. Lupus 22(9):953–956CrossRefPubMed
91.
Zurück zum Zitat Loricera J, Blanco R, Hernández J, Carril J, Martínez-Rodríguez I, Canga A, Peiró E, Alonso-Gutiérrez J, Calvo-Río V, Ortiz-Sanjuán F (2015) Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review. Clin Exp Rheumatol 33(2 Suppl 89):S19 Loricera J, Blanco R, Hernández J, Carril J, Martínez-Rodríguez I, Canga A, Peiró E, Alonso-Gutiérrez J, Calvo-Río V, Ortiz-Sanjuán F (2015) Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review. Clin Exp Rheumatol 33(2 Suppl 89):S19
92.
Zurück zum Zitat Kaneko S, Yamashita H, Sugimori Y, Takahashi Y, Kaneko H, Kano T, Mimori A (2014) Rheumatoid arthritis-associated aortitis: a case report and literature review. Springerplus 3:509CrossRefPubMedPubMedCentral Kaneko S, Yamashita H, Sugimori Y, Takahashi Y, Kaneko H, Kano T, Mimori A (2014) Rheumatoid arthritis-associated aortitis: a case report and literature review. Springerplus 3:509CrossRefPubMedPubMedCentral
94.
Zurück zum Zitat Chirinos JA, Tamariz LJ, Lopes G, Del Carpio F, Zhang X, Milikowski C, Lichtstein DM (2004) Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol 23(2):152–159CrossRefPubMed Chirinos JA, Tamariz LJ, Lopes G, Del Carpio F, Zhang X, Milikowski C, Lichtstein DM (2004) Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol 23(2):152–159CrossRefPubMed
95.
Zurück zum Zitat Palazzi C, Salvarani C, D’Angelo S, Olivieri I (2011) Aortitis and periaortitis in ankylosing spondylitis. Jt Bone Spine 78(5):451–455CrossRef Palazzi C, Salvarani C, D’Angelo S, Olivieri I (2011) Aortitis and periaortitis in ankylosing spondylitis. Jt Bone Spine 78(5):451–455CrossRef
96.
Zurück zum Zitat Tufan A, Tezcan ME, Kaya A, Mercan R, Oner Y, Ozturk MA (2012) Aortitis in a patient with psoriatic arthritis. Mod Rheumatol 22(5):774–777CrossRefPubMed Tufan A, Tezcan ME, Kaya A, Mercan R, Oner Y, Ozturk MA (2012) Aortitis in a patient with psoriatic arthritis. Mod Rheumatol 22(5):774–777CrossRefPubMed
97.
Zurück zum Zitat Chapelon-Abric C, Saadoun D, Marie I, Comarmond C, Desbois AC, Domont F, Savey L, Cacoub P (2018) Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review. Int J Rheum Dis 21(3):740–745CrossRefPubMed Chapelon-Abric C, Saadoun D, Marie I, Comarmond C, Desbois AC, Domont F, Savey L, Cacoub P (2018) Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review. Int J Rheum Dis 21(3):740–745CrossRefPubMed
98.
Zurück zum Zitat Ho AC, Roat MI, Venbrux A, Hellmann DB (1999) Cogan’s syndrome with refractory abdominal aortitis and mesenteric vasculitis. J Rheumatol 26(6):1404–1407PubMed Ho AC, Roat MI, Venbrux A, Hellmann DB (1999) Cogan’s syndrome with refractory abdominal aortitis and mesenteric vasculitis. J Rheumatol 26(6):1404–1407PubMed
100.
101.
Zurück zum Zitat DomÈnech E, Garcia-Planella E, OlazÁbal A, SÁnchez-Delgado J, Zabana Y, Bernal I, Mañosa M, Olivé A, Gassull MA (2005) Abdominal aortitis associated with Crohn’s disease. Dig Dis Sci 50(6):1122–1123CrossRefPubMed DomÈnech E, Garcia-Planella E, OlazÁbal A, SÁnchez-Delgado J, Zabana Y, Bernal I, Mañosa M, Olivé A, Gassull MA (2005) Abdominal aortitis associated with Crohn’s disease. Dig Dis Sci 50(6):1122–1123CrossRefPubMed
102.
Zurück zum Zitat Tsui K-L, Lee K-W, Chan W-K, Chan HK-Y, Hon SF-K, Leung T-C, Lee K-L, Tsoi T-H, Li S-K (2004) Behçet’s aortitis and aortic regurgitation: a report of two cases. J Am Soc Echocardiogr 17(1):83–86CrossRefPubMed Tsui K-L, Lee K-W, Chan W-K, Chan HK-Y, Hon SF-K, Leung T-C, Lee K-L, Tsoi T-H, Li S-K (2004) Behçet’s aortitis and aortic regurgitation: a report of two cases. J Am Soc Echocardiogr 17(1):83–86CrossRefPubMed
103.
Zurück zum Zitat Stone JH, Khosroshahi A, Deshpande V, Stone JR (2010) IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res 62(3):316–322CrossRef Stone JH, Khosroshahi A, Deshpande V, Stone JR (2010) IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res 62(3):316–322CrossRef
105.
Zurück zum Zitat Schmidt J, Sunesen K, Kornum JB, Duhaut P, Thomsen RW (2011) Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study. Arthritis Res Ther 13(3):R87CrossRefPubMedPubMedCentral Schmidt J, Sunesen K, Kornum JB, Duhaut P, Thomsen RW (2011) Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study. Arthritis Res Ther 13(3):R87CrossRefPubMedPubMedCentral
106.
Zurück zum Zitat Liang KP, Chowdhary VR, Michet CJ, Miller DV, Sundt TM, Connolly HM, Crowson CS, Matteson EL, Warrington KJ (2009) Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol 36(10):2290–2297CrossRefPubMed Liang KP, Chowdhary VR, Michet CJ, Miller DV, Sundt TM, Connolly HM, Crowson CS, Matteson EL, Warrington KJ (2009) Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol 36(10):2290–2297CrossRefPubMed
107.
Zurück zum Zitat Talarico R, Boiardi L, Pipitone N, d’Ascanio A, Stagnaro C, Ferrari C, Elefante E, Salvarani C, Bombardieri S (2014) Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? Clin Exp Rheumatol 32(3 Suppl 82):S55–S58PubMed Talarico R, Boiardi L, Pipitone N, d’Ascanio A, Stagnaro C, Ferrari C, Elefante E, Salvarani C, Bombardieri S (2014) Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? Clin Exp Rheumatol 32(3 Suppl 82):S55–S58PubMed
108.
Zurück zum Zitat Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, Yazici H (2006) Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65(9):1202–1207CrossRefPubMedPubMedCentral Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, Yazici H (2006) Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65(9):1202–1207CrossRefPubMedPubMedCentral
109.
Zurück zum Zitat Seyahi E, Ucgul A, Olgun DC, Ugurlu S, Akman C, Tutar O, Yurdakul S, Yazici H (2013) Aortic and coronary calcifications in Takayasu arteritis. Semin Arthritis Rheum 43(1):96–104CrossRefPubMed Seyahi E, Ucgul A, Olgun DC, Ugurlu S, Akman C, Tutar O, Yurdakul S, Yazici H (2013) Aortic and coronary calcifications in Takayasu arteritis. Semin Arthritis Rheum 43(1):96–104CrossRefPubMed
110.
Zurück zum Zitat Wasserman BA (2010) Advanced contrast-enhanced MRI for looking beyond the lumen to predict stroke: building a risk profile for carotid plaque. Stroke 41(10 suppl 1):S12–S16CrossRefPubMed Wasserman BA (2010) Advanced contrast-enhanced MRI for looking beyond the lumen to predict stroke: building a risk profile for carotid plaque. Stroke 41(10 suppl 1):S12–S16CrossRefPubMed
111.
Zurück zum Zitat Hoffman GS (2003) Large-vessel vasculitis: unresolved issues. Arthritis Rheum Off J Am Coll Rheumatol 48(9):2406–2414CrossRef Hoffman GS (2003) Large-vessel vasculitis: unresolved issues. Arthritis Rheum Off J Am Coll Rheumatol 48(9):2406–2414CrossRef
112.
Zurück zum Zitat Pipitone N, Versari A, Salvarani C (2008) Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology 47(4):403–408CrossRefPubMed Pipitone N, Versari A, Salvarani C (2008) Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology 47(4):403–408CrossRefPubMed
113.
Zurück zum Zitat Blockmans D (2003) The use of (18F) fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 21(6:SUPP/32):S15–S22PubMed Blockmans D (2003) The use of (18F) fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 21(6:SUPP/32):S15–S22PubMed
114.
Zurück zum Zitat Salonen JT, Salonen R (1993) Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87(3 Suppl):II56–II65PubMed Salonen JT, Salonen R (1993) Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87(3 Suppl):II56–II65PubMed
115.
Zurück zum Zitat Maeda H, Handa N, Matsumoto M, Hougaku H, Ogawa S, Oku N, Itoh T, Moriwaki H, Yoneda S, Kimura K (1991) Carotid lesions detected by B-mode ultrasonography in Takayasu’s arteritis: “macaroni sign” as an indicator of the disease. Ultrasound Med Biol 17(7):695–701CrossRefPubMed Maeda H, Handa N, Matsumoto M, Hougaku H, Ogawa S, Oku N, Itoh T, Moriwaki H, Yoneda S, Kimura K (1991) Carotid lesions detected by B-mode ultrasonography in Takayasu’s arteritis: “macaroni sign” as an indicator of the disease. Ultrasound Med Biol 17(7):695–701CrossRefPubMed
116.
Zurück zum Zitat Sigl M, Hsu E, Scheffel H, Haneder S, Rumenapf G, Amendt K (2014) Lower extremity vasculitis in giant cell arteritis: important differential diagnosis in patients with lower limb claudication. Vasa 43(5):326–336CrossRefPubMed Sigl M, Hsu E, Scheffel H, Haneder S, Rumenapf G, Amendt K (2014) Lower extremity vasculitis in giant cell arteritis: important differential diagnosis in patients with lower limb claudication. Vasa 43(5):326–336CrossRefPubMed
117.
Zurück zum Zitat Bao N, Cao H-R, Zhang W-H, Zhang Y (2013) Arteritis mimicking aortic coarctation and review of the literature. JMC 4(6):376–379 Bao N, Cao H-R, Zhang W-H, Zhang Y (2013) Arteritis mimicking aortic coarctation and review of the literature. JMC 4(6):376–379
118.
Zurück zum Zitat Janzen J, Vuong PN, Rothenberger-Janzen K (1999) Takayasu’s arteritis and fibromuscular dysplasia as causes of acquired atypical coarctation of the aorta: retrospective analysis of seven cases. Heart Vessels 14(6):277–282CrossRefPubMed Janzen J, Vuong PN, Rothenberger-Janzen K (1999) Takayasu’s arteritis and fibromuscular dysplasia as causes of acquired atypical coarctation of the aorta: retrospective analysis of seven cases. Heart Vessels 14(6):277–282CrossRefPubMed
119.
Zurück zum Zitat Delis KT, Gloviczki P (2005) Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment. Perspect Vasc Surg Endovasc Ther 17(3):187–203CrossRefPubMed Delis KT, Gloviczki P (2005) Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment. Perspect Vasc Surg Endovasc Ther 17(3):187–203CrossRefPubMed
121.
Zurück zum Zitat Milewicz DM, Dietz HC, Miller DC (2005) Treatment of aortic disease in patients with Marfan syndrome. Circulation 111(11):e150–e157CrossRefPubMed Milewicz DM, Dietz HC, Miller DC (2005) Treatment of aortic disease in patients with Marfan syndrome. Circulation 111(11):e150–e157CrossRefPubMed
122.
Zurück zum Zitat Pepin M, Schwarze U, Superti-Furga A, Byers PH (2000) Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Engl J Med 342(10):673–680CrossRefPubMed Pepin M, Schwarze U, Superti-Furga A, Byers PH (2000) Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Engl J Med 342(10):673–680CrossRefPubMed
123.
Zurück zum Zitat Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S (2006) Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 355(8):788–798CrossRefPubMed Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S (2006) Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 355(8):788–798CrossRefPubMed
124.
Zurück zum Zitat Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123(1):124–133CrossRefPubMed Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123(1):124–133CrossRefPubMed
126.
Zurück zum Zitat Olin JW, Sealove BA (2011) Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg 53(3):826–836CrossRefPubMed Olin JW, Sealove BA (2011) Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg 53(3):826–836CrossRefPubMed
127.
Zurück zum Zitat Churchill CH, Abril A, Krishna M, Callman ML, Ginsburg WW (2003) Jaw claudication in primary amyloidosis: unusual presentation of a rare disease. J Rheumatol 30(10):2283–2286PubMed Churchill CH, Abril A, Krishna M, Callman ML, Ginsburg WW (2003) Jaw claudication in primary amyloidosis: unusual presentation of a rare disease. J Rheumatol 30(10):2283–2286PubMed
128.
Zurück zum Zitat Salvarani C, Gabriel SE, Gertz MA, Bjornsson J, Li CY, Hunder GG (1994) Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum Off J Am Coll Rheumatol 37(11):1621–1626CrossRef Salvarani C, Gabriel SE, Gertz MA, Bjornsson J, Li CY, Hunder GG (1994) Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum Off J Am Coll Rheumatol 37(11):1621–1626CrossRef
129.
Zurück zum Zitat Estrada-Veras JI, O’Brien KJ, Boyd LC, Dave RH, Durham BH, Xi L, Malayeri AA, Chen MY, Gardner PJ, Enriquez JRA (2017) The clinical spectrum of Erdheim–Chester disease: an observational cohort study. Blood Adv 1(6):357–366CrossRefPubMedPubMedCentral Estrada-Veras JI, O’Brien KJ, Boyd LC, Dave RH, Durham BH, Xi L, Malayeri AA, Chen MY, Gardner PJ, Enriquez JRA (2017) The clinical spectrum of Erdheim–Chester disease: an observational cohort study. Blood Adv 1(6):357–366CrossRefPubMedPubMedCentral
130.
Zurück zum Zitat Baker-LePain JC, Stone DH, Mattis AN, Nakamura MC, Fye KH (2010) Clinical diagnosis of segmental arterial mediolysis: differentiation from vasculitis and other mimics. Arthritis Care Res 62(11):1655–1660CrossRef Baker-LePain JC, Stone DH, Mattis AN, Nakamura MC, Fye KH (2010) Clinical diagnosis of segmental arterial mediolysis: differentiation from vasculitis and other mimics. Arthritis Care Res 62(11):1655–1660CrossRef
131.
Zurück zum Zitat Mertz LE, Conn DL (1992) Vasculitis associated with malignancy. Curr Opin Rheumatol 4(1):39–46PubMed Mertz LE, Conn DL (1992) Vasculitis associated with malignancy. Curr Opin Rheumatol 4(1):39–46PubMed
Metadaten
Titel
Diagnosis and differential diagnosis of large-vessel vasculitides
verfasst von
Gokhan Keser
Kenan Aksu
Publikationsdatum
17.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 2/2019
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4157-3

Weitere Artikel der Ausgabe 2/2019

Rheumatology International 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.